SkinHealth Systems Inc. Income Statement
SKIN|5 years of annual SEC 10-K data (FY2021-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 5 fiscal years. All figures from audited SEC 10-K filings.
SkinHealth Systems Inc. reported $398M in revenue and $100M in net loss for FY2025. Revenue has grown at a 24.3% compound annual rate over the past 4 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $398.0M | $365.9M | $260.1M | $119.1M | $166.6M |
| Cost of Revenue | $242.9M | $117.1M | $81.5M | $51.9M | $60.1M |
| Gross Profit | $155.1M | $248.8M | $178.5M | $67.2M | $106.5M |
| SG&A Expense | $131.4M | $106.1M | $98.7M | $30.6M | $26.7M |
| R&D Expense | $10.1M | $8.4M | $8.2M | $3.4M | $4.6M |
| Operating Income | -$130.9M | -$25.8M | -$39.9M | -$17.2M | $13.5M |
| Interest Expense | - | - | $11.8M | - | - |
| Income Tax | -$1.8M | $1.1M | -$1.9M | -$9.3M | -$1.3M |
| Net Income | -$100.1M | $44.2M | -$378.8M | -$29.2M | -$1.6M |
| EPS (Basic) | -$0.76 | $0.30 | -$3.71 | -$0.85 | -$0.05 |
| EPS (Diluted) | -$0.76 | -$0.23 | -$3.71 | -$0.85 | -$0.05 |
| Shares Outstanding | 124.9M | 122.9M | 54.4K | 54.4K | 32.1M |
| Gross Margin | 39.0% | 68.0% | 68.7% | 56.4% | 63.9% |
| Operating Margin | -32.9% | -7.1% | -15.3% | -14.4% | 8.1% |
| Profit Margin | -25.2% | 12.1% | -145.6% | -24.5% | -1.0% |